Intangible assets and goodwill (Tables)

12 Months Ended

Dec. 31, 2025

Veraxa Biotech A G [Member]

Entity Information [Line Items]

Schedule of intangible assets and goodwill

		Goodwill				In process R&D (Flysin)				Trademark rights				Software				Total

Cost
Beginning Cost at 12/31/2023		₣	22,848,728			₣	28,498,755			₣	31,261,245			₣	48,857			₣	82,657,585
Disposals			-				-				-				(7,999	)			(7,999	)
FX effects			-				-				1,272				-				1,272
Ending Cost at 12/31/2024		₣	22,848,728			₣	28,498,755			₣	31,262,517			₣	40,858			₣	82,650,858
Additions			-				-				-				-				-
FX effects			-				-				816				8				824
Ending Cost at 12/31/2025		₣	22,848,728			₣	28,498,755			₣	31,263,333			₣	40,866			₣	82,651,682

Accumulated depreciation
Balance at 12/31/2023		₣	-			₣	-			₣	(4,696,411	)		₣	(37,253	)		₣	(4,733,664	)
Amortization for the year			-				-				(1,579,717	)			(7,597	)			(1,587,314	)
Disposals			-				-				-				4,140				4,140
Balance at 12/31/2024			-				-				(6,276,128	)			(40,710	)			(6,316,838	)
Amortization for the year			-				-				(1,577,997	)			(156	)			(1,578,153	)
Balance at 12/31/2025		₣	-			₣	-			₣	(7,854,125	)		₣	(40,866	)		₣	(7,894,991	)

Carrying Amount
at 12/31/2024		₣	22,848,728			₣	28,498,755			₣	24,986,389			₣	148			₣	76,334,020
at 12/31/2025		₣	22,848,728			₣	28,498,755			₣	23,409,208			₣	-			₣	74,756,691